The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

ARROWHEAD PHARMACEUTICALS, INC. insider acquisitions

Company CIK 0000879407 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
ARWR · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Anzalone Christopher RichardAnzalone Christopher Rich…Vakiener VictoriaVakiener VictoriaLu HongboLu HongboWaddill William D.Waddill William D.Ferrari MauroFerrari MauroPERRY MICHAEL SPERRY MICHAEL SOLUKOTUN ADEOYE YOLUKOTUN ADEOYE YINGRAM DOUGLAS SINGRAM DOUGLAS SAnzalone Christopher Richard · December 29, 2025 · Exercise / conversion · Common StockAnzalone Christopher Richard · December 29, 2025 · Exercise / conversion · Common StockVakiener Victoria · December 16, 2025 · Stock award · Common StockLu Hongbo · December 16, 2025 · Stock award · Common StockWaddill William D. · December 16, 2025 · Stock award · Common StockFerrari Mauro · December 16, 2025 · Stock award · Common StockPERRY MICHAEL S · December 16, 2025 · Stock award · Common StockOLUKOTUN ADEOYE Y · December 16, 2025 · Stock award · Common StockINGRAM DOUGLAS S · December 16, 2025 · Stock award · Common StockAnzalone Christopher Richard · December 12, 2025 · Stock award · Common StockDec 12, 2025Dec 29, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

10 dated transactions · 8 of 8 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 29, 2025ARROWHEAD PHARMACEUTICALS, INC.Common StockAnzalone Christopher RichardExercise / conversion
Dec 29, 2025ARROWHEAD PHARMACEUTICALS, INC.Common StockAnzalone Christopher RichardExercise / conversion
Dec 16, 2025ARROWHEAD PHARMACEUTICALS, INC.Common StockVakiener VictoriaStock award
Dec 16, 2025ARROWHEAD PHARMACEUTICALS, INC.Common StockLu HongboStock award
Dec 16, 2025ARROWHEAD PHARMACEUTICALS, INC.Common StockWaddill William D.Stock award
Dec 16, 2025ARROWHEAD PHARMACEUTICALS, INC.Common StockFerrari MauroStock award
Dec 16, 2025ARROWHEAD PHARMACEUTICALS, INC.Common StockPERRY MICHAEL SStock award
Dec 16, 2025ARROWHEAD PHARMACEUTICALS, INC.Common StockOLUKOTUN ADEOYE YStock award
Dec 16, 2025ARROWHEAD PHARMACEUTICALS, INC.Common StockINGRAM DOUGLAS SStock award
Dec 12, 2025ARROWHEAD PHARMACEUTICALS, INC.Common StockAnzalone Christopher RichardStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

ARWR · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Anzalone Christopher RichardChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M16,5456.15Value: 101,751.75Currency not specifiedView ↗
Trade:
Anzalone Christopher RichardChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M35,1816.15Value: 216,363.15Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A7,8190Value: 0Currency not specifiedView ↗
Trade:
Lu HongboDirector
Stock awardCommon StockNon-derivative security · Code A7,8190Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A7,8190Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A7,8190Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A7,8190Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A7,8190Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A7,8190Value: 0Currency not specifiedView ↗
Trade:
Anzalone Christopher RichardChief Executive Officer · Director
Stock awardCommon StockNon-derivative security · Code A180,0000Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →